Resources
See our solutions in action
Case Studies
The proof is in the pudding, as they say. Learn how we have helped clients achieve significant savings with minimal effort and impact to their members and patients.
Pharmacy is a volume-based business: compare your company’s size with those of our clients to estimate what the savings could be for you.
TruDataRx Insights
White Papers
Select a white paper to learn more about our use of Comparative Effectiveness Research and how it compares to the FDA’s drug approval process.
Webinars
For self-insured employers, the talk about “potential” lawsuits is over – it’s here, and we’re all at risk. Please find below a webinar exploring the implications for fiduciaries of the recent lawsuit against J&J.
The suit claims Johnson & Johnson breached its fiduciary duty by failing to prudently manage its pharmacy benefit. Essentially, they traded control of their formulary for “guarantees” from conflicted entities.
We’re honored to be partnering with Chris Deacon, JD, healthcare thought leader and former director of one of the largest self-funded health plans in the country for the State of New Jersey.
In this webinar, you will learn:
- What the lawsuit is alleging
- What this means for self-insured employers
- Concrete steps you can do today to understanding your risk and exposure
- How utilizing Comparative Effectiveness Research drives clinical value and reduces costs
We had an opportunity to sit down with Jerry Avorn, M.D., author of Powerful Medicines and Rethinking Medications, to dive into the “last mile” problem of healthcare: ensuring patients get the most effective, safest, and most affordable medications in a system filled with hidden costs and conflicting incentives.
In this webinar, you will learn:
- The power of evidence: How comparative effectiveness research (CER) can bridge the gap between clinical science and everyday prescribing
- Navigating costs: An inside look at the “wild west” of drug pricing, including the impact of middlemen, rebates, and the hidden dollar flows that drive up expenditures
- The role of payers: Why self-insured employers are uniquely positioned to use clinical data to rightsize formularies and improve healthcare affordability for their employees
- FDA realities: A candid look at what FDA approval actually means and why standards for new drugs are not always what they seem